|
1
|
Sell S: Stem cell origin of cancer and
differentiation therapy. Crit Rev Oncol Hematol. 51:1–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wicha MS, Liu S and Dontu G: Cancer stem
cells: An old idea-A paradigm shift. Cancer Res. 66:1883–1890.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brabletz T, Jung A, Spaderna S, Hlubek F
and Kirchner T: Opinion: Migrating cancer stem cells-an integrated
concept of malignant tumour progression. Nat Rev Cancer. 5:744–749.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carpentino JE, Hynes MJ, Appelman HD,
Zheng T, Steindler DA, Scott EW and Huang EH: Aldehyde
dehydrogenase-expressing colon stem cells contribute to
tumorigenesis in the transition from colitis to cancer. Cancer Res.
69:8208–8215. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han L, Shi S, Gong T, Zhang Z and Sun X:
Cancer stem cells: Therapeutic implications and perspectives in
cancer therapy. Acta Pharm Sin B. 3:65–75. 2013. View Article : Google Scholar
|
|
6
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
8
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dou J, Pan M, Wen P, Li Y, Tang Q, Chu L,
Zhao F, Jiang C, Hu W, Hu K and Gu N: Isolation and identification
of cancer stem-like cells from murine melanoma cell lines. Cell Mol
Immunol. 4:467–472. 2007.PubMed/NCBI
|
|
12
|
Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB,
Liu W, Qi Q, Lu N, Tao L, Wang XT, et al: Isolation and
characterization of cancer stem like cells in human glioblastoma
cell lines. Cancer Lett. 279:13–21. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Allikmets R, Gerrard B, Hutchinson A and
Dean M: Characterization of the human ABC superfamily: Isolation
and mapping of 21 new genes using the expressed sequence tags
database. Hum Mol Genet. 5:1649–1655. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mikhail S and Zeidan A: Stem cells in
gastrointestinal cancers: The road less travelled. World J Stem
Cells. 6:606–613. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou J, Wang CY, Liu T, Wu B, Zhou F,
Xiong JX, Wu HS, Tao J, Zhao G, Yang M and Gou SM: Persistence of
side population cells with high drug efflux capacity in pancreatic
cancer. World J Gastroenterol. 14:925–930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Golebiewska A, Brons NH, Bjerkvig R and
Niclou SP: Critical appraisal of the side population assay in stem
cell and cancer stem cell research. Cell Stem Cell. 8:136–147.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yoshida A, Rzhetsky A, Hsu LC and Chang C:
Human aldehyde dehydrogenase gene family. Eur J Biochem.
251:549–557. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Langan RC, Mullinax JE, Raiji MT, Upham T,
Summers T, Stojadinovic A and Avital I: Colorectal cancer
biomarkers and the potential role of cancer stem cells. J Cancer.
4:241–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sussman RT, Ricci MS, Hart LS, Sun SY and
El-Deiry WS: Chemotherapy-resistant side-population of colon cancer
cells has a higher sensitivity to TRAIL than the non-SP, a higher
expression of c-Myc and TRAIL-receptor DR4. Cancer Biol Ther.
6:1490–1495. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leibovitz A, Stinson JC, McCombs WB III,
McCoy CE, Mazur KC and Mabry ND: Classification of human colorectal
adenocarcinoma cell lines. Cancer Res. 36:4562–4569.
1976.PubMed/NCBI
|
|
23
|
Goodell BM, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dontu G, Al-Hajj M, Abdallah WM, Clarke MF
and Wicha MS: Stem cells in normal breast development and breast
cancer. Cell Prolif. 36 Suppl 1:S59–S72. 2003. View Article : Google Scholar
|
|
25
|
Kreso A and O'Brien CA: Colon cancer stem
cells. Curr Protoc Stem Cell Biol Chapter. 3:Unit 3.1. 2008.
View Article : Google Scholar
|
|
26
|
López J, Poitevin A, Mendoza-Martínez V,
Pérez-Plasencia C and García-Carrancá A: Cancer-initiating cells
derived from established cervical cell lines exhibit stem-cell
markers and increased radioresistance. BMC Cancer. 12:482012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang
R, Li J, Zhang Y, Chen L, Qian H, et al: Sphere-forming cell
subpopulations with cancer stem cell properties in human hepatoma
cell lines. BMC Gastroenterol. 11:712011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Many AM and Brown AM: Both canonical and
non-canonical Wnt signaling independently promote stem cell growth
in mammospheres. PLoS One. 9:e1018002014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Collins K, Jacks T and Pavletich NP: The
cell cycle and cancer. Proc Natl Acad Sci USA. 94:2776–2778. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Anderson EC, Hessman C, Levin TG, Monroe
MM and Wong MH: The role of colorectal cancer stem cells in
metastatic disease and therapeutic response. Cancers (Basel).
3:319–339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Constant S, Huang S, Wiszniewski L and Mas
C: Colon cancer: Current treatments and preclinical models for the
discovery and development of new therapies. Drug Discov. 433–458.
2012.
|
|
32
|
Hewitt RE, McMarlin A, Kleiner D, Wersto
R, Martin P, Tsokos M, Stamp GW and Stetler-Stevenson WG:
Validation of a model of colon cancer progression. J Pathol.
192:446–454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Botchkina IL, Rowehl RA, Rivadeneira DE,
Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y and
Botchkina GI: Phenotypic subpopulations of metastatic colon cancer
stem cells: Genomic analysis. Cancer Genomics Proteomics. 6:19–29.
2009.PubMed/NCBI
|
|
34
|
Calvet CY, André FM and Mir L: The culture
of cancer cell lines as tumorspheres does not systematically result
in cancer stem cell enrichment. PLoS One. 9:e896442014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haraguchi N, Utsunomiya T, Inoue H, Tanaka
F, Mimori K, Barnard GF and Mori M: Characterization of a side
population of cancer cells from human gastrointestinal system. Stem
Cells. 24:506–513. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang DD, Kim YJ, Lee CN, Aggarwal S,
McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM and Moore
PA: Expansion of CD133(+) colon cancer cultures retaining stem cell
properties to enable cancer stem cell target discovery. Br J
Cancer. 102:1265–1275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu CS, Tung CY, Yang CY and Lin CH:
Response to stress in early tumor colonization modulates switching
of CD133-positive and CD133-negative subpopulations in a human
metastatic colon cancer cell line, SW620. PLoS One. 8:e611332013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Melcher R, Steinlein C, Feichtinger W,
Müller CR, Menzel T, Lührs H, Scheppach W and Schmid M: Spectral
karyotyping of the human colon cancer cell lines SW480 and SW620.
Cytogenet Cell Genet. 88:145–152. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kolquist KA, Ellisen LW, Counter CM,
Meyerson M, Tan LK, Weinberg RA, Haber DA and Gerald WL: Expression
of TERT in early premalignant lesions and a subset of cells in
normal tissues. Nat Genet. 19:182–186. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gerbin CS and Landgraf R: Geldanamycin
selectively targets the nascent form of ERBB3 for degradation. Cell
Stress Chaperones. 15:529–544. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kim RH, Kim R, Chen W, Hu S, Shin KH, Park
NH and Kang MK: Association of hsp90 to the hTERT promoter is
necessary for hTERT expression in human oral cancer cells.
Carcinogenesis. 29:2425–2431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yuan H, Veldman T, Rundell K and Schlegel
R: Simian virus 40 small tumor antigen activates AKT and telomerase
and induces anchorage-independent growth of human epithelial cells.
J Virol. 76:10685–10691. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu D, Zhang R, Zhao R, Chen G, Cai Y and
Jin J: A novel function of novobiocin: disrupting the interaction
of HIF 1α and p300/CBP through direct binding to the HIF1α
C-terminal activation domain. PLoS One. 8:e620142013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hieronymus H, Lamb J, Ross KN, Peng XP,
Clement C, Rodina A, Nieto M, Du J, Stegmaier K, Raj SM, et al:
Gene expression signature-based chemical genomic prediction
identifies a novel class of HSP90 pathway modulators. Cancer Cell.
10:321–330. 2006. View Article : Google Scholar : PubMed/NCBI
|
